Clinical trial
S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer
NCT00003549 · SWOG Cancer Research Network, Other · Completed
Key facts
| NCT number | NCT00003549 |
|---|---|
| Title | S9716: Combination Chemotherapy in Treating Patients With Merkel Cell Cancer |
| Official title | A Phase II Trial of Cyclophosphamide, Methotrexate and 5-Fluorouracil (CMF) in Neuroendocrine Carcinoma of the Skin (Merkel Cell Carcinoma) |
| Lead sponsor | SWOG Cancer Research Network, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Neuroendocrine Carcinoma of the Skin |
| Intervention type | Drug |
| Interventions | CMF regimen, cyclophosphamide, fluorouracil, methotrexate |
| Enrollment | 80 |
| Start date | Oct 1, 1998 |
| Primary completion | Sep 1, 2001 |
| Completion | Jan 1, 2003 |
| First posted | Jun 24, 2004 |
| Last update posted | Oct 8, 2012 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: